UW Medicine says benefit of FDA-approved 2nd booster shot is 'very marginal'

Deutschland Nachrichten Nachrichten

UW Medicine says benefit of FDA-approved 2nd booster shot is 'very marginal'
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 fox13seattle
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 59%

The FDA has authorized a second COVID-19 booster shot for people ages 50 and up, but researchers at UW Medicine believe the benefits are limited. FOX13

This decision from the FDA still requires approval from the Centers for Disease Control and Prevention , but would allow immunocompromised people and anyone ages 50 and up to get a fourth shot of the vaccine, either Pfizer or Moderna. They would become eligible four months after their first booster shot.

UW Medicine clinical virologist Dr. Anna Wald says that, for people over age 50, the benefits of another booster shot are not many. "I think the benefit is very marginal in that population," said Wald. "These vaccines that are currently available do not seem to prevent infection very effectively. But they do work really well, even in three doses, to prevent hospitalization and death."

Wald is the medical director for UW Medicine's virology research clinic at Harborview, which is currently"What we really need is a new approach," said Wald, "a vaccine that's different and that would provide, I think, broader and longer lasting immunity so that we would not have to be getting boosters every six months."

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

fox13seattle /  🏆 328. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

FDA expected to OK 4th COVID-19 vaccine dose for adults over 50, UW doctor weighs inFDA expected to OK 4th COVID-19 vaccine dose for adults over 50, UW doctor weighs inThe FDA is expected to give its authorization for a fourth COVID-19 vaccine dose for Americans 50 and older as early as Tuesday.
Weiterlesen »

FDA approves 2nd COVID-19 vaccine booster for those 50 and olderFDA approves 2nd COVID-19 vaccine booster for those 50 and olderU.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine.
Weiterlesen »

FDA authorizes 2nd booster shot for Americans over 50The decision now moves over to the CDC, where Director Rochelle Walensky will issue instructions on how to implement the authorization.
Weiterlesen »

FDA authorizes 2nd booster shot for Americans over 50FDA authorizes 2nd booster shot for Americans over 50The FDA's decision opens a fourth dose of the Pfizer or Moderna vaccines to that age group at least four months after their previous booster.
Weiterlesen »

NPR Cookie Consent and Choices
Weiterlesen »

FDA expected to authorize 2nd booster shot for Americans over 50FDA expected to authorize 2nd booster shot for Americans over 50Time for a boost? FDA expected to OK second booster shot for some people. Who may want to get it & who should wait. Now on ABC7
Weiterlesen »



Render Time: 2025-03-04 07:14:16